Hexagon Nutrition IPO GMP Day 2 (8 June 2026): Rs 12 GMP, Retail Subscribed 2.43x, Listing 12 June BSE NSE

The Hexagon Nutrition IPO is on Day 2 of its subscription window on 8 June 2026 with the grey market premium standing at Rs 12 per share, implying an estimated listing price of approximately Rs 57 against the upper issue price of Rs 45, a premium of 26.7%. This mainboard offering is entirely structured as an Offer for Sale (OFS) of Rs 138.87 crore, meaning the company receives no fresh capital. The issue opened on 5 June and closes on 9 June 2026, with shares scheduled to debut on both BSE and NSE on 12 June 2026.

Day 1 (5 June 2026) subscription data showed the retail category subscribed 2.43 times by close, while QIBs had not yet placed bids. This early retail momentum is positive, as institutional participation typically concentrates on the final day. The Hexagon Nutrition IPO anchor round on 4 June 2026 raised Rs 41.66 crore from Bandhan Small Cap Fund, Ampersand Growth Opportunities Fund, CP Capital, Visionary Value Fund, and Innovative Vision Fund, with 9.258 million equity shares allotted at Rs 45 per share.

About Hexagon Nutrition Limited

Hexagon Nutrition Limited, incorporated in 1993 and headquartered in Nashik, Maharashtra, is a research-driven nutrition company with over three decades of operations. The Hexagon Nutrition IPO gives investors access to one of India’s few integrated nutrition companies, with operations spanning micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use food products.

The company operates three manufacturing facilities in India: Nashik (Maharashtra), Chennai, and Thoothukudi (Tamil Nadu), along with an international unit in Tashkent, Uzbekistan. Two Indian facilities are located in SEZ zones, providing duty-free import advantages and port proximity. Hexagon Nutrition is also among the largest licensed suppliers of Micronutrient Powders (MNPs) under United Nations food fortification programmes. Post-IPO, promoter holding will reduce from 89.41% to 64.29%, with the company valued at approximately Rs 553 crore market cap.

Revenue grew to Rs 331.29 crore in FY25 from Rs 304.62 crore in FY24, while PAT nearly doubled to Rs 24.38 crore from Rs 12.21 crore in FY24. The company exports to over 75 countries, adding a diversified revenue profile to the investment case.

Hexagon Nutrition IPO Key Details

Detail	Information
Issue Type	Book Built Mainboard IPO (100% OFS)
Issue Size	Rs 138.87 Crore
Price Band	Rs 42 to Rs 45 per share
Lot Size	333 shares
Min Investment (Retail)	Rs 14,985 (333 shares)
Open / Close Date	5 June 2026 / 9 June 2026
Allotment Date	10 June 2026
Listing Date	12 June 2026 (BSE and NSE)
Registrar	KFin Technologies Ltd.
GMP (Day 2)	Rs 12 per share (26.7% premium)

Hexagon Nutrition IPO GMP Day 2: What the Premium Signals

The Hexagon Nutrition IPO GMP of Rs 12 on Day 2 implies a potential listing price of Rs 57, a 26.7% gain over the upper issue price of Rs 45. The GMP has ranged between Rs 10 and Rs 13 since the pre-open period, with a high of Rs 13 on Day 1 (5 June). A consistent double-digit GMP on a mainboard issue backed by early retail oversubscription of 2.43x on Day 1 reflects healthy market sentiment.

The fully OFS nature of the issue is one factor to note. Since the company receives no proceeds, there is no direct growth catalyst from the IPO. QIB participation on the final subscription day (9 June 2026) will be the key data point. Strong QIB interest would significantly validate the GMP-implied listing outcome for the Hexagon Nutrition IPO. GMP is unofficial and not regulated by SEBI.

Subscription Status and Investment Considerations

The accessible minimum investment of Rs 14,985 (333 shares) has contributed to early retail oversubscription of 2.43x on Day 1. This is one of the lowest retail entry points among mainboard IPOs in the current cycle and opens this issue to a wide investor base. The NII segment is expected to build through Days 2 and 3, while QIBs will finalise positions on 9 June 2026.

Longer-term investors should assess the company’s ability to sustain FY25 PAT growth and scale its clinical nutrition and therapeutic food segments globally. The export presence across 75 countries and UN programme contracts provide revenue diversification. Investors should consult a SEBI-registered advisor and review the RHP before applying to the Hexagon Nutrition IPO.

Check Live IPO and Stock Data on the Univest Screener

Allotment and Listing Timeline

The Hexagon Nutrition IPO closes on 9 June 2026. Allotment will be finalised on 10 June 2026, with share credits on 11 June 2026. The listing on BSE and NSE is scheduled for 12 June 2026. Investors can check their allotment status on the KFin Technologies registrar website or the BSE and NSE allotment pages after 10 June 2026 using their PAN or application number.

Download the Univest iOS App or Univest Android App to track the Hexagon Nutrition share price and allotment status live.

Conclusion

The Hexagon Nutrition IPO GMP of Rs 12 on Day 2 signals healthy grey market confidence, supported by strong retail demand of 2.43x on Day 1 and marquee anchor investor participation. With a low minimum investment of Rs 14,985 and a PAT that doubled in FY25, the issue presents an accessible entry point into India’s nutrition sector. Monitor QIB data on 9 June and verify all figures from official BSE and NSE sources. Consult a SEBI-registered advisor before investing.

Frequently Asked Questions on Hexagon Nutrition IPO GMP Day 2

What is the Hexagon Nutrition IPO GMP on Day 2?

Ans. The Hexagon Nutrition IPO GMP on Day 2 (8 June 2026) is Rs 12 per share, implying an expected listing price of approximately Rs 57 against the upper issue price of Rs 45, a premium of around 26.7%. GMP is unofficial and not regulated by SEBI.

What is the price band and lot size?

Ans. The price band is Rs 42 to Rs 45 per share. The minimum lot size is 333 shares. The minimum retail investment is Rs 14,985 at the upper price band, making this one of the most accessible mainboard IPOs of the current cycle.

Is the Hexagon Nutrition IPO a fresh issue or OFS?

Ans. The Hexagon Nutrition IPO is entirely an Offer for Sale (OFS) of up to 3,08,59,704 equity shares by promoters. The company will not receive any proceeds from the IPO. All funds raised go to the selling shareholders.

When is the Hexagon Nutrition IPO listing date?

Ans. The Hexagon Nutrition IPO is scheduled to list on both BSE and NSE on 12 June 2026. Allotment is expected on 10 June 2026, with share credits on 11 June 2026.

What does Hexagon Nutrition do?

Ans. Hexagon Nutrition Limited, incorporated in 1993 and headquartered in Nashik, is a research-driven nutrition company manufacturing micronutrient premixes, branded wellness and clinical nutrition products, therapeutic formulations, and ready-to-use foods. It operates facilities in Nashik, Chennai, Thoothukudi, and Tashkent (Uzbekistan).

How did Hexagon Nutrition perform in FY25?

Ans. Revenue grew to Rs 331.29 crore in FY25 from Rs 304.62 crore in FY24. PAT nearly doubled to Rs 24.38 crore in FY25 from Rs 12.21 crore in FY24, reflecting strong margin improvement and operating leverage across nutrition segments.

Who were the anchor investors in the Hexagon Nutrition IPO?

Ans. The Hexagon Nutrition IPO raised Rs 41.66 crore from anchor investors on 4 June 2026. Key participants included Bandhan Small Cap Fund, Ampersand Growth Opportunities Fund, CP Capital, Visionary Value Fund, and Innovative Vision Fund, each allotted shares at Rs 45.

Where to check allotment status?

Ans. After allotment on 10 June 2026, investors can check status on the KFin Technologies registrar website, or on BSE or NSE allotment pages, using their PAN or application number.